Literature DB >> 25640959

Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Luisa Iommarini1, Susana Peralta2, Alessandra Torraco3, Francisca Diaz4.   

Abstract

Mitochondrial disorders are defined as defects that affect the oxidative phosphorylation system (OXPHOS). They are characterized by a heterogeneous array of clinical presentations due in part to a wide variety of factors required for proper function of the components of the OXPHOS system. There is no cure for these disorders owing to our poor knowledge of the pathogenic mechanisms of disease. To understand the mechanisms of human disease numerous mouse models have been developed in recent years. Here we summarize the features of several mouse models of mitochondrial diseases directly related to those factors affecting mtDNA maintenance, replication, transcription, translation as well as other proteins that are involved in mitochondrial dynamics and quality control which affect mitochondrial OXPHOS function without being intrinsic components of the system. We discuss how these models have contributed to our understanding of mitochondrial diseases and their pathogenic mechanisms.
Copyright © 2015 © Elsevier B.V. and Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mitochondrial DNA; Mitochondrial diseases; Mitochondrial dynamics; Mitochondrial transcription; Mouse models; Quality control

Mesh:

Year:  2015        PMID: 25640959      PMCID: PMC4447541          DOI: 10.1016/j.mito.2015.01.008

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  254 in total

1.  Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice.

Authors:  Henna Tyynismaa; Katja Peltola Mjosund; Sjoerd Wanrooij; Ilse Lappalainen; Emil Ylikallio; Anu Jalanko; Johannes N Spelbrink; Anders Paetau; Anu Suomalainen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

2.  Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility.

Authors:  Hang Yin; John S Stahl; Francisco H Andrade; Colleen A McMullen; Sarah Webb-Wood; Nancy J Newman; Valerie Biousse; Douglas C Wallace; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

3.  The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions.

Authors:  Alicia M Pickrell; Hirokazu Fukui; Xiao Wang; Milena Pinto; Carlos T Moraes
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

4.  Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastructural and immunohistochemical investigations.

Authors:  Angela M Meyer zum Gottesberge; Heidi Felix
Journal:  Histochem Cell Biol       Date:  2005-07-26       Impact factor: 4.304

5.  Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy.

Authors:  Ivano Di Meo; Gigliola Fagiolari; Alessandro Prelle; Carlo Viscomi; Massimo Zeviani; Valeria Tiranti
Journal:  Antioxid Redox Signal       Date:  2011-02-25       Impact factor: 8.401

6.  Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy.

Authors:  Nicholas Joza; Gavin Y Oudit; Doris Brown; Paule Bénit; Zamaneh Kassiri; Nicola Vahsen; Loralyn Benoit; Mikin M Patel; Karin Nowikovsky; Anne Vassault; Peter H Backx; Teiji Wada; Guido Kroemer; Pierre Rustin; Josef M Penninger
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  Biochemical analysis of human POLG2 variants associated with mitochondrial disease.

Authors:  Matthew J Young; Matthew J Longley; Fang-Yuan Li; Rajesh Kasiviswanathan; Lee-Jun Wong; William C Copeland
Journal:  Hum Mol Genet       Date:  2011-05-09       Impact factor: 6.150

8.  A family of putative transcription termination factors shared amongst metazoans and plants.

Authors:  Tomas Linder; Chan Bae Park; Jordi Asin-Cayuela; Mina Pellegrini; Nils-Göran Larsson; Maria Falkenberg; Tore Samuelsson; Claes M Gustafsson
Journal:  Curr Genet       Date:  2005-11-04       Impact factor: 3.886

9.  Increase in mitochondrial DNA mutations impairs retinal function and renders the retina vulnerable to injury.

Authors:  Yu X G Kong; Nicole Van Bergen; Ian A Trounce; Bang V Bui; Vicki Chrysostomou; Hayley Waugh; Algis Vingrys; Jonathan G Crowston
Journal:  Aging Cell       Date:  2011-04-07       Impact factor: 9.304

Review 10.  Mitochondrial DNA mutations and depletion in pediatric medicine.

Authors:  A Spinazzola
Journal:  Semin Fetal Neonatal Med       Date:  2011-06-08       Impact factor: 3.926

View more
  12 in total

Review 1.  The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism.

Authors:  Senta M Kapnick; Susan E Pacheco; Peter J McGuire
Journal:  Metabolism       Date:  2017-11-21       Impact factor: 8.694

Review 2.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

3.  hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells.

Authors:  Lakshmi Sripada; Kritarth Singh; Anastasiya V Lipatova; Aru Singh; Paresh Prajapati; Dhanendra Tomar; Khyati Bhatelia; Milton Roy; Rochika Singh; Madan M Godbole; Peter M Chumakov; Rajesh Singh
Journal:  J Mol Med (Berl)       Date:  2017-02-20       Impact factor: 4.599

4.  Enhanced glycolysis and GSK3 inactivation promote brain metabolic adaptations following neuronal mitochondrial stress.

Authors:  Sofia Garcia; Amy Saldana-Caboverde; Mir Anwar; Ami Pravinkant Raval; Nadee Nissanka; Milena Pinto; Carlos Torres Moraes; Francisca Diaz
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

5.  ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels.

Authors:  Susana Peralta; Steffi Goffart; Sion L Williams; Francisca Diaz; Sofia Garcia; Nadee Nissanka; Estela Area-Gomez; Jaakko Pohjoismäki; Carlos T Moraes
Journal:  J Cell Sci       Date:  2018-07-04       Impact factor: 5.285

Review 6.  Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders.

Authors:  Christopher Auger; Azhar Alhasawi; Manuraj Contavadoo; Vasu D Appanna
Journal:  Front Cell Dev Biol       Date:  2015-06-25

7.  H55N polymorphism is associated with low citrate synthase activity which regulates lipid metabolism in mouse muscle cells.

Authors:  Brendan M Gabriel; Mustafa Al-Tarrah; Yosra Alhindi; Audrius Kilikevicius; Tomas Venckunas; Stuart R Gray; Arimantas Lionikas; Aivaras Ratkevicius
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 8.  The Peroxisome-Mitochondria Connection: How and Why?

Authors:  Marc Fransen; Celien Lismont; Paul Walton
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

Review 9.  The genetics and pathology of mitochondrial disease.

Authors:  Charlotte L Alston; Mariana C Rocha; Nichola Z Lax; Doug M Turnbull; Robert W Taylor
Journal:  J Pathol       Date:  2016-11-02       Impact factor: 7.996

Review 10.  Review: Central nervous system involvement in mitochondrial disease.

Authors:  N Z Lax; G S Gorman; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2016-07-07       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.